EmblemHealth, one of the nation’s largest not-for-profit health plans, today announced the citywide expansion of its Community Diabetes Wellness Program. Originally launched in the Bronx, the program ...

All the latest (ASX:ALC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia.

Discusses Developments in Diabetes With Emphasis on Icovamenib and Clinical Trial Insights May 5, 2026 2:30 PM ...

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a ...

Ozempic (semaglutide) and Mounjaro (tirzepatide) are injectable type 2 diabetes medications prescribed to lower blood sugar, ...

In this guide, learn the eligibility criteria for brand-name semaglutide, cost and insurance coverage, safety risks of compounded semaglutide and how to find a reputable telehealth provider online.

Total Revenue -- $164.9 million, up from $157.2 million the previous year; reflects increasing prescriptions and patient volume. Prescription Trends -- Record levels of new prescriptions, new patient ...

Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...

Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.

Operator: Thank you for standing by, and welcome to Corcept Therapeutics First Quarter 2026 Earnings Conference Call.

DUBLIN, May 01, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB) (“Trinity” or the “Company”), a commercial‑stage diagnostics and health technology company, today announced the appointment ...

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, April 29, 2026 /CNW/ — USANewsGroup.com News Commentary – There’s a quiet bidding war underway for AI diagnostics, and the price ...